AlphaYouMR
Insider selling
Max Rosett sold $1.1M of Immunome Inc. (IMNM) stock
Max Rosett, Chief Financial Officer of Immunome Inc. (IMNM), sold 60,000 shares of IMNM stock worth $1.1M, per an SEC Form 4 filed Jun 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 15, 2026, 2 days before it was made public.
IMNM has moved +38.7% since the trade date, from $18.07 to $25.07 (Sep 21, 2026 close).
- Traded
- Jun 15, 2026
- Disclosed
- Jun 17, 2026
- Filing delay
- 2 days
- Price since
- +38.7%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More IMNM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.